CSWYF (China Shineway Pharmaceutical Group) Operating Margin %: 23.53% (As of Dec. 2025) — 16% Above Median


CSWYF China Shineway Pharmaceutical Group Ltd CSWYF
92 GF Score
Price $1.00
GF Value $0.88
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Operating Margin %?

China Shineway Pharmaceutical Group CSWYF 92 Operating Margin % is 23.53% as of Dec. 2025, which is 16% above its 10-year median of 20.25. GuruFocus rates CSWYF with a GF Score™ of 92/100 and a GF Value™ of $0.88. The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 86.6% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. China Shineway Pharmaceutical Group's Operating Income for the six months ended in Dec. 2025 was $49.5 Mil. China Shineway Pharmaceutical Group's Revenue for the six months ended in Dec. 2025 was $210.5 Mil. Therefore, China Shineway Pharmaceutical Group's Operating Margin % for the quarter that ended in Dec. 2025 was 23.53%.

Good Sign:

China Shineway Pharmaceutical Group Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for China Shineway Pharmaceutical Group's Operating Margin % or its related term are showing as below:

CSWYF' s Operating Margin % Range Over the Past 10 Years
Min: 16.17   Med: 20.25   Max: 29.27
Current: 22.9


CSWYF's Operating Margin % is ranked better than
86.6% of 955 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs CSWYF: 22.90

China Shineway Pharmaceutical Group's 5-Year Average Operating Margin % Growth Rate was 8.20% per year.

China Shineway Pharmaceutical Group's Operating Income for the six months ended in Dec. 2025 was $49.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $100.9 Mil.


China Shineway Pharmaceutical Group  (OTCPK:CSWYF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


China Shineway Pharmaceutical Group Operating Margin % Related Terms


China Shineway Pharmaceutical Group Operating Margin % Historical Data

* Premium members only.

The historical data trend for China Shineway Pharmaceutical Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group Operating Margin % Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.79 18.29 21.60 22.30 22.89

China Shineway Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.10 27.07 16.42 22.32 23.53

CSWYF vs ZTS: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Shineway Pharmaceutical Group Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Operating Margin % falls into.


CSWYF
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYF
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Shineway Pharmaceutical Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

China Shineway Pharmaceutical Group's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=101.914 / 445.17
=22.89 %

China Shineway Pharmaceutical Group's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=49.532 / 210.518
=23.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 23.53% mean?
China Shineway Pharmaceutical Group (CSWYF) has a Operating Margin % of 23.53% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 16% above median its historical median of 20.25. Over the past decade, China Shineway Pharmaceutical Group's Operating Margin % has ranged from 16.17 to 29.27. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #128 out of 955 companies in the Drug Manufacturers industry, placing it in the top 13.4%.
Is China Shineway Pharmaceutical Group's Operating Margin % too high?
China Shineway Pharmaceutical Group's current Operating Margin % of 23.53% is 16% above median its 10-year median of 20.25. Over the past 10 years, this metric has ranged from a low of 16.17 to a high of 29.27. The Drug Manufacturers industry median Operating Margin % is 7.45. China Shineway Pharmaceutical Group's value of 23.53% is 215.8% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #128 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #128 out of 955 companies for Operating Margin %. This places China Shineway Pharmaceutical Group in the top 13% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. China Shineway Pharmaceutical Group's value of 23.53% is 215.8% above this benchmark. Historically, China Shineway Pharmaceutical Group's own Operating Margin % has ranged from 16.17 to 29.27 over the past decade. While the company's 10-year median is 20.25 vs. the industry median of 7.45, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Operating Margin % of 23.53% is 215.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Operating Margin % is 23.53%, which is 16% above median its own 10-year median of 20.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current Operating Margin % of 23.53%. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current Operating Margin % is 23.53%, which is 16% above median its 10-year median of 20.25 and 215.8% above the Drug Manufacturers industry median of 7.45. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current Operating Margin % is 23.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.

Key valuation signals for CSWYF:

  • Operating Margin %: 23.53% (16% above median its 10-year median of 20.25)
  • GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
  • GF Score™: 92/100 with 2 warning signs
  • Industry Position: 215.8% above the Drug Manufacturers median (#128 of 955)

No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYF

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$0.88
GF Value